BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 36535562)

  • 1. Role of cardiac magnetic resonance in the differential diagnosis between arrhythmogenic cardiomyopathy with left ventricular involvement and previous infectious myocarditis.
    Colombo D; Turco A; Lomi S; Valentini A; Bassi E; Scelsi L; Greco A; Schirinzi S; Zacchino M; Acquaro M; Oliveri F; Preda L; Ghio S
    Int J Cardiol; 2023 Mar; 374():120-126. PubMed ID: 36535562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac magnetic resonance features of left dominant arrhythmogenic cardiomyopathy: differential diagnosis with myocarditis.
    Andreini D; Conte E; Casella M; Mushtaq S; Pontone G; Dello Russo A; Nicoli F; Carità P; Catto V; Vettor G; Gasperetti A; Sommariva E; Rizzo S; Basso C; Tondo C; Pepi M
    Int J Cardiovasc Imaging; 2022 Feb; 38(2):397-405. PubMed ID: 34546457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic Cardiac Magnetic Resonance Markers of Left Ventricular Involvement in Arrhythmogenic Cardiomyopathy for Predicting Heart Failure Outcomes.
    Chun KH; Oh J; Hong YJ; Yu HT; Lee CJ; Kim TH; Joung B; Pak HN; Lee MH; Kim YJ; Kang SM
    J Am Heart Assoc; 2022 Mar; 11(6):e023167. PubMed ID: 35261277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Left ventricular involvement assessed by LGE-CMR in predicting the risk of adverse outcomes of arrhythmogenic cardiomyopathy with ICDs.
    Zhang N; Song Y; Hua W; Hu Y; Chen L; Cai M; Niu H; Cai C; Gu M; Zhao S; Zhang S
    Int J Cardiol; 2021 Aug; 337():79-85. PubMed ID: 33839174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognosis evaluation of chronic inflammatory cardiomyopathy with ring-like late gadolinium enhancement.
    Wang H; Bo K; Gao Y; Zhou Z; Xu L
    ESC Heart Fail; 2023 Jun; 10(3):1735-1744. PubMed ID: 36843322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic and Prognostic Value of Cardiac Magnetic Resonance Strain in Suspected Myocarditis With Preserved LV-EF: A Comparison Between Patients With Negative and Positive Late Gadolinium Enhancement Findings.
    Chen Y; Sun Z; Xu L; Liu J; Li Y; Zhang N; Liu D; Wen Z
    J Magn Reson Imaging; 2022 Apr; 55(4):1109-1119. PubMed ID: 34369030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic Value of Right Ventricular Function in Patients With Suspected Myocarditis Undergoing Cardiac Magnetic Resonance.
    Bernhard B; Schnyder A; Garachemani D; Fischer K; Tanner G; Safarkhanlo Y; Stark AW; Schütze J; Pavlicek-Bahlo M; Greulich S; Johner C; Wahl A; Benz DC; Kwong RY; Gräni C
    JACC Cardiovasc Imaging; 2023 Jan; 16(1):28-41. PubMed ID: 36599567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A distinct septal pattern of late gadolinium enhancement specific for COVID-induced myocarditis: A multicenter cardiovascular magnetic resonance study.
    Haberka M; Rajewska-Tabor J; Wojtowicz D; Jankowska A; Miszalski-Jamka K; Janus M; Dorniak K; Kulawiak-Gałąska D; Stasiow B; Rozmiarek S; Fijałkowska J; Elikowski W; Ławrynowicz M; Śpiewak M; Koziński M; Pyda M
    Kardiol Pol; 2023; 81(5):463-471. PubMed ID: 36871296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative changes in late gadolinium enhancement at cardiac magnetic resonance in the early phase of acute myocarditis.
    Ammirati E; Moroni F; Sormani P; Peritore A; Milazzo A; Quattrocchi G; Cipriani M; Oliva F; Giannattasio C; Frigerio M; Roghi A; Camici PG; Pedrotti P
    Int J Cardiol; 2017 Mar; 231():216-221. PubMed ID: 27913009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac magnetic resonance in histologically proven eosinophilic myocarditis.
    Pöyhönen P; Rågback J; Mäyränpää MI; Nordenswan HK; Lehtonen J; Shenoy C; Kupari M
    J Cardiovasc Magn Reson; 2023 Dec; 25(1):79. PubMed ID: 38105221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ringlike late gadolinium enhancement provides incremental prognostic value in non-classical arrhythmogenic cardiomyopathy.
    Yang Y; Wei X; Lu G; Xie J; Tan Z; Du Z; Ye W; Xu H; Li X; Liu E; Zhang Q; Liu Y; Li J; Liu H
    J Cardiovasc Magn Reson; 2023 Nov; 25(1):72. PubMed ID: 38031154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Left and right ventricular morphology, function and late gadolinium enhancement extent and localization change with different clinical presentation of acute myocarditis Data from the ITAlian multicenter study on MYocarditis (ITAMY).
    Di Bella G; Camastra G; Monti L; Dellegrottaglie S; Piaggi P; Moro C; Pepe A; Lanzillo C; Pontone G; Perazzolo Marra M; Di Roma M; Scatteia A; Aquaro GD;
    J Cardiovasc Med (Hagerstown); 2017 Nov; 18(11):881-887. PubMed ID: 28915139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of late gadolinium enhancement on left atrial impairment in myocarditis patients.
    Cau R; Muscogiuri G; Pisu F; Mannelli L; Sironi S; Suri JS; Pontone G; Saba L
    Eur Radiol; 2024 Mar; 34(3):1846-1853. PubMed ID: 37658889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimal timing of follow-up cardiac magnetic resonance in patients with uncomplicated acute myocarditis.
    Pieroni M; Ciabatti M; Zocchi C; Tavanti V; Camporeale A; Saletti E; Fumagalli C; Venezia D; Lombardi M; Olivotto I; Bolognese L
    Int J Cardiol; 2024 Feb; 397():131603. PubMed ID: 37979787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regional Strain by Cardiac Magnetic Resonance Imaging Improves Detection of Right Ventricular Scar Compared With Late Gadolinium Enhancement on a Multimodality Scar Evaluation in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy.
    Zghaib T; Ghasabeh MA; Assis FR; Chrispin J; Keramati A; Misra S; Berger R; Calkins H; Kamel I; Nazarian S; Zimmerman S; Tandri H
    Circ Cardiovasc Imaging; 2018 Sep; 11(9):e007546. PubMed ID: 30354675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arrhythmogenic Right Ventricular Cardiomyopathy: Characterization of Left Ventricular Phenotype and Differential Diagnosis With Dilated Cardiomyopathy.
    Cipriani A; Bauce B; De Lazzari M; Rigato I; Bariani R; Meneghin S; Pilichou K; Motta R; Aliberti C; Thiene G; McKenna WJ; Zorzi A; Iliceto S; Basso C; Perazzolo Marra M; Corrado D
    J Am Heart Assoc; 2020 Mar; 9(5):e014628. PubMed ID: 32114891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two-dimensional speckle-tracking-derived segmental peak systolic longitudinal strain identifies regional myocardial involvement in patients with myocarditis and normal global left ventricular systolic function.
    Uppu SC; Shah A; Weigand J; Nielsen JC; Ko HH; Parness IA; Srivastava S
    Pediatr Cardiol; 2015 Jun; 36(5):950-9. PubMed ID: 25617227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship between the quantitative extent of late gadolinium enhancement and burden of nonsustained ventricular tachycardia in hypertrophic cardiomyopathy: A delayed contrast-enhanced magnetic resonance study.
    Weissler-Snir A; Hindieh W; Spears DA; Adler A; Rakowski H; Chan RH
    J Cardiovasc Electrophysiol; 2019 May; 30(5):651-657. PubMed ID: 30680853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical experience regarding safety and diagnostic value of cardiovascular magnetic resonance in patients with a subcutaneous implanted cardioverter/defibrillator (S-ICD) at 1.5 T.
    Holtstiege V; Meier C; Bietenbeck M; Chatzantonis G; Florian A; Köbe J; Reinke F; Eckardt L; Yilmaz A
    J Cardiovasc Magn Reson; 2020 May; 22(1):35. PubMed ID: 32418537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early Left Ventricular Involvement Detected by Cardiovascular Magnetic Resonance Feature Tracking in Arrhythmogenic Right Ventricular Cardiomyopathy: The Effects of Left Ventricular Late Gadolinium Enhancement and Right Ventricular Dysfunction.
    Chen X; Li L; Cheng H; Song Y; Ji K; Chen L; Han T; Lu M; Zhao S
    J Am Heart Assoc; 2019 Sep; 8(17):e012989. PubMed ID: 31441357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.